Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants

Clinical trial NCT00320463 · COMPLETED

Trial details

NCT number: NCT00320463
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diphtheria Hepatitis B Poliomyelitis Tetanus Acellular Pertussis

Start date: 2006-04-01
Enrollment: 415

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.